1. Home
  2. ACMR vs EWTX Comparison

ACMR vs EWTX Comparison

Compare ACMR & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACMR
  • EWTX
  • Stock Information
  • Founded
  • ACMR 1998
  • EWTX 2017
  • Country
  • ACMR United States
  • EWTX United States
  • Employees
  • ACMR N/A
  • EWTX N/A
  • Industry
  • ACMR Industrial Machinery/Components
  • EWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACMR Technology
  • EWTX Health Care
  • Exchange
  • ACMR Nasdaq
  • EWTX Nasdaq
  • Market Cap
  • ACMR 1.3B
  • EWTX 1.5B
  • IPO Year
  • ACMR 2017
  • EWTX 2021
  • Fundamental
  • Price
  • ACMR $29.48
  • EWTX $14.31
  • Analyst Decision
  • ACMR Buy
  • EWTX Buy
  • Analyst Count
  • ACMR 5
  • EWTX 9
  • Target Price
  • ACMR $30.50
  • EWTX $39.89
  • AVG Volume (30 Days)
  • ACMR 917.6K
  • EWTX 600.2K
  • Earning Date
  • ACMR 08-06-2025
  • EWTX 08-11-2025
  • Dividend Yield
  • ACMR N/A
  • EWTX N/A
  • EPS Growth
  • ACMR 19.75
  • EWTX N/A
  • EPS
  • ACMR 1.57
  • EWTX N/A
  • Revenue
  • ACMR $802,274,000.00
  • EWTX N/A
  • Revenue This Year
  • ACMR $19.67
  • EWTX N/A
  • Revenue Next Year
  • ACMR $15.50
  • EWTX N/A
  • P/E Ratio
  • ACMR $18.76
  • EWTX N/A
  • Revenue Growth
  • ACMR 26.21
  • EWTX N/A
  • 52 Week Low
  • ACMR $13.87
  • EWTX $10.60
  • 52 Week High
  • ACMR $32.54
  • EWTX $38.12
  • Technical
  • Relative Strength Index (RSI)
  • ACMR 52.64
  • EWTX 54.06
  • Support Level
  • ACMR $29.12
  • EWTX $13.94
  • Resistance Level
  • ACMR $32.54
  • EWTX $15.33
  • Average True Range (ATR)
  • ACMR 1.15
  • EWTX 0.62
  • MACD
  • ACMR -0.15
  • EWTX 0.10
  • Stochastic Oscillator
  • ACMR 25.73
  • EWTX 49.75

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the global semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: